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CASE REPORT
Multimodal imaging of bilateral diffuse 
uveal melanocytic proliferation associated 
with an iris mass lesion
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Abstract 
Background: Bilateral diffuse uveal melanocytic proliferation (BDUMP) is a rare, paraneoplastic syndrome character-
ized by bilateral painless visual loss and proliferation of choroidal melanocytes in association with an underlying sys-
temic malignancy. We report a case of bilateral diffuse uveal melanocytic proliferation associated with an underlying 
gynecological malignancy that also features the infrequent finding of an iris mass lesion, using multimodal imaging 
including ultra-widefield imaging, spectral domain and swept-source optical coherence tomography.
Case presentation: A 59-year-old white female with a prior history of gynecological malignancy in remission 
presented with progressive bilateral visual loss over several weeks. The patient was noted to have a focal iris mass 
lesion in her right eye. Ultra-widefield color fundus photography showed a characteristic bilateral ‘giraffe pattern’ 
of pigmentary changes extending into the periphery as well as multiple discrete deeply pigmented lesions. Ultra-
widefield autofluorescence was useful for visualizing the full extent of involvement. Indocyanine green angiography 
helped to demarcate the discrete pigmented choroidal lesions. Swept-source OCT clearly delineated the alternating 
zones of retinal pigment epithelium (RPE) thickening and RPE loss, as well as the prominent choroidal infiltration and 
thickening.
Conclusions: BDUMP is an important diagnosis to consider in the presence of multiple discrete melanocytic cho-
roidal lesions, diffuse choroidal thickening, characteristic RPE changes, iris mass lesions and exudative retinal detach-
ment. Ultra-widefield imaging may demonstrate more extensive lesions than that detected on clinical examination or 
standard field imaging. Imaging with SS-OCT shows choroidal and RPE characteristics that correlate well with known 
histopathology of this entity.
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Background
Bilateral diffuse uveal melanocytic proliferation 
(BDUMP) is a rare, paraneoplastic syndrome character-
ized by bilateral painless, profound visual loss in associa-
tion with an underlying systemic malignancy [1]. In 1966, 
Machemer et al. [2] first described this clinical syndrome, 
although it was not until 1982 that Barr et al. [3] coined 
the term BDUMP. In 1990, Gass et al. [4] described the 
five cardinal signs of BDUMP as: (1) multiple orange-red 
subretinal patches; (2) early hyperfluorescence on fluo-
rescein angiography; (3) multiple elevated pigmented and 
non-pigmented uveal melanocytic tumors with diffuse 
choroidal thickening; (4) exudative retinal detachments; 
and (5) rapidly progressive cataracts.
Since then, about 50 cases have been described in the 
literature [5–32] and the primary malignancy typically 
involves the reproductive tract in women, and gastroin-
testinal or respiratory system in men. We report an unu-
sual case of BDUMP in a patient with a history of ovarian 
carcinoma. This case also displayed the uncommon 
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finding of an iris mass lesion, which has been rarely 
described in this entity. This case of BDUMP was evalu-
ated with multimodal imaging techniques that included 
ultra-widefield color and autofluorescence (AF); indo-
cyanine green angiography (ICGA); and spectral-domain 
(SD) and swept-source (SS) optical coherence tomogra-
phy (OCT).
Case presentation
A 59-year-old white female presented with complaints 
of decreasing vision and photophobia over the prior 
month. Her medical history was notable for hyperten-
sion and chemotherapy for ovarian carcinoma 5  years 
prior to presentation. On examination, her best-cor-
rected visual acuity was 20/40 OD and 20/80 OS. The 
anterior segment examination was remarkable for a 
pigmented, vascularized iris mass lesion at the superior 
pupillary border in her right eye (Fig. 1). Her intraocu-
lar pressures were normal. Funduscopic examination 
and color fundus photography (Topcon TRC-50XF; 
Topcon Medical Systems, Oakland, NJ) showed bilateral 
exudative macular detachments with multiple scattered 
darkly pigmented choroidal lesions (Fig. 2a). The extent 
of the pathology was better seen with ultra-widefield 
color images (Optos 200Tx; Optos, Scotland, United 
Kingdom) (Fig.  2b). RPE changes forming a ‘giraffe-
pattern’ were noted in the posterior pole of both eyes. 
Ultra-widefield autofluorescence (AF) imaging (Optos 
200Tx; Optos, Scotland, United Kingdom) highlighted 
and documented the full extent of this pattern with 
patches of hypo-AF alternating with intervening areas 
of hyper-AF (Fig. 2c). Fundus camera based ICGA (Top-
con TRC-50XF; Topcon Medical Systems, Oakland, 
NJ) showed the scattered darkly pigmented choroidal 
lesions as well-circumscribed hypofluorescent areas 
(Fig. 2d). 
SD-OCT (Heidelberg Spectralis: Heidelberg Engineer-
ing, Heidelberg, Germany) showed areas of subretinal 
fluid and discrete hyper-reflective choroidal lesions that 
appear to be compressing the adjacent choriocapillaris. 
The choroidal lesions were highly reflective on near-
infrared reflectance (nIR) (Fig.  3a–c). Enhanced depth 
imaging OCT (EDI-OCT) performed with the Heidel-
berg Spectralis showed diffuse choroidal thickening 
beneath the exudative macular detachments (Fig.  3d, 
e). Swept-source OCT (DRI OCT-1; Topcon Medical 
Systems, Oakland, NJ) of the right eye showed alternat-
ing RPE thickening and RPE loss that corresponded to 
the appearance of the “giraffe-pattern” seen on the AF 
(Fig. 4).
The patient was referred back to her oncologist for fur-
ther evaluation of a presumed recurrence of her ovarian 
carcinoma.
Conclusions
We present a case of BDUMP using multimodal imaging 
including the use of ultra-widefield imaging, ICG angi-
ography and SS-OCT that helped to show the full extent 
of the posterior segment disease. Ultra-widefield color 
fundus photography allowed greater visualization of pig-
mentary changes and multiple pigmented lesions in the 
periphery, while ultra-widefield AF accentuated the char-
acteristic ‘giraffe-pattern’ fundus changes which were 
more difficult to appreciate on clinical examination. EDI-
OCT and SS-OCT readily showed choroidal thickening 
and alternating zones of RPE thickening and RPE loss. 
These findings correlate well with the known histopathol-
ogy of BDUMP. The choroid is diffusely thickened with 
uveal melanocytic cells including nevoid, spindle cells, 
and epithelioid cells. There are also aggregates of focal 
Fig. 1 Color photograph of patient’s right eye showing a superior 
iris melanocytic lesion (a). Higher magnification view of the iris lesion 
displaying the pigmented mass with some associated vascularity (b)
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Fig. 2 Standard flood-illuminated and Ultra-wide field (UWF) color photographs show multiple scattered melanocytic lesions throughout the fun-
dus associated with pigmentary changes extending from the posterior pole (a, b). UWF AF shows round-like patches of hypo-AF alternating with 
intervening areas of hyper-AF in the posterior pole (c). ICG angiography shows these scattered melanocytic lesions to be hypofluorescent (d)
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Fig. 3 Spectral-domain optical coherence tomography (SD-OCT) with matching near-infrared reflectance (nIR) localizes these discrete lesions 
to the choroid with compression of the choriocapillaris (red arrow) and associated subretinal fluid (blue arrow). The choroidal lesions are intensely 
hyper-reflective on nIR images (a–c). EDI-OCT shows markedly increased choroidal thickness with overlying subretinal fluid of the right (d) and left 
eyes (e)
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infiltration of pigmented melanocytes in the choroid with 
overlying areas of RPE destruction alternating with areas 
of RPE hypertrophy [1].
Of the approximately 50 cases of BDUMP reported in 
literature [1–33], only 6 cases have reported the associa-
tion with iris tumors. [3, 20, 34–37] Originally described 
by Gass et al. [4] iris involvement is infrequently seen or 
documented. We highlight this uncommon occurrence to 
create awareness that BDUMP can lead to infiltration of 
the uveal tract including the iris and ciliary body, which 
may further lead to angle-closure glaucoma and cataracts.
Various treatments for BDUMP, including ocular radia-
tion [1, 3, 19, 32], subretinal fluid drainage [30] and corti-
costeroids [15, 16, 24, 35] have been tried without success. 
Recently, plasmapheresis has been shown to improve vis-
ual acuity in few case reports. [1, 11] The rationale is to 
decrease the circulating autoantibodies, [1, 11, 24] shown 
to be in the IgG fragment termed cultured melanocyte 
elongation and proliferation (CMEP) factor, [38] which 
stimulates cutaneous and uveal melanocyte cell prolifera-
tion. However, success with this treatment has been lim-
ited. The overall prognosis for BDUMP is poor with the 
majority of patients passing within 3  years [39]. Treat-
ment of the underlying systemic malignancy is crucial.
In summary, we show the benefit of multimodal imag-
ing in BDUMP to demonstrate the full extent of the 
disease. We highlight the occurrence of iris lesions in this 
condition and the difficulties with treatment options.
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